System for screening out of Severe Combined Immunodeficiency on neonates

2014 |

The EnLite Neonatal TREC system developed by Perkin Elmer is globally the first diagnostics product used for the screening for hereditary severe combined immunodeficiency (SCID). The screening method allows the identification of babies with this immune deficiency disease as neonates.  If the child is treated for the condition by the time they reach the age of 6 months, they have a 95 per cent chance of recovery. Without treatment, the disease usually leads to the death of the child by the time they are two.

The invention made by PerkinElmer’s Turku product development unit is unique in that the screening for the immune deficiency disease can be done without the isolation of DNA.